Additionally, fullerene nanomaterials have been demonstrated to mitigate TNF-α secretion by scavenging excessive ROS or modulating redox homeostasis, thereby suppressing the activation of inflammation-associated signaling pathways such as NF-κB and MAPK/ERK in tumor microenvironment [14, 61]. This evidence concerns the gene TNF and neoplasm.